Nancy V Le

Array ( [id] => 1313628 [patent_doc_number] => 06610737 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Non-psychotropic cannabinoids' [patent_app_type] => B1 [patent_app_number] => 10/304074 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16682 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 401 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610737.pdf [firstpage_image] =>[orig_patent_app_number] => 10304074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856838 [patent_doc_number] => 20030130339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'ALPHA, BETA-UNSATURATED SULFONES FOR TREATING PROLIFERATIVE DISORDERS' [patent_app_type] => new [patent_app_number] => 10/301332 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9725 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130339.pdf [firstpage_image] =>[orig_patent_app_number] => 10301332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1216944 [patent_doc_number] => 06706756 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-16 [patent_title] => 'Vasodilating compound and method of use' [patent_app_type] => B1 [patent_app_number] => 10/065770 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 2469 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706756.pdf [firstpage_image] =>[orig_patent_app_number] => 10065770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797620 [patent_doc_number] => 20030176494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Novel coumarin and chromene compounds and methods of preparation and use thereof for treating or preventing viral infections' [patent_app_type] => new [patent_app_number] => 10/295340 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31727 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176494.pdf [firstpage_image] =>[orig_patent_app_number] => 10295340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 535798 [patent_doc_number] => 07176217 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Azabicyclo compound matrix metalloprotease inhibitor and skin preparation' [patent_app_type] => utility [patent_app_number] => 10/495370 [patent_app_country] => US [patent_app_date] => 2002-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16166 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176217.pdf [firstpage_image] =>[orig_patent_app_number] => 10495370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1197119 [patent_doc_number] => 06727277 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-27 [patent_title] => 'Compounds affecting cholesterol absorption' [patent_app_type] => B1 [patent_app_number] => 10/292720 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16721 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727277.pdf [firstpage_image] =>[orig_patent_app_number] => 10292720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1339138 [patent_doc_number] => 06593481 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Hydrogenation of 3,4-tetrahydrofurandiol to tetrahydrofuran' [patent_app_type] => B1 [patent_app_number] => 10/292557 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3715 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593481.pdf [firstpage_image] =>[orig_patent_app_number] => 10292557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 501777 [patent_doc_number] => 07205407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => '3-Substituted oxindole β3 agonists' [patent_app_type] => utility [patent_app_number] => 10/495085 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11729 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/205/07205407.pdf [firstpage_image] =>[orig_patent_app_number] => 10495085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660251 [patent_doc_number] => 20030134895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Method for the preparation of citalopram' [patent_app_type] => new [patent_app_number] => 10/291174 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4262 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134895.pdf [firstpage_image] =>[orig_patent_app_number] => 10291174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207857 [patent_doc_number] => 20050043399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Dimeric compounds and their use as anti-viral agents' [patent_app_type] => utility [patent_app_number] => 10/494241 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6967 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043399.pdf [firstpage_image] =>[orig_patent_app_number] => 10494241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163683 [patent_doc_number] => 20050085533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Novel mandelates salts of substituted tetracyclic tetrahydrofuran derivatives' [patent_app_type] => utility [patent_app_number] => 10/491799 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6157 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085533.pdf [firstpage_image] =>[orig_patent_app_number] => 10491799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 479013 [patent_doc_number] => 07223790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Dimeric compounds and their use as anti-viral agents' [patent_app_type] => utility [patent_app_number] => 10/494260 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7458 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223790.pdf [firstpage_image] =>[orig_patent_app_number] => 10494260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 490094 [patent_doc_number] => 07214707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-08 [patent_title] => 'Dimeric compounds and their use as anti-viral agents' [patent_app_type] => utility [patent_app_number] => 10/494242 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8970 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/214/07214707.pdf [firstpage_image] =>[orig_patent_app_number] => 10494242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 559616 [patent_doc_number] => 07157494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Dimeric compounds and their use as anti-viral agents' [patent_app_type] => utility [patent_app_number] => 10/494243 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9791 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157494.pdf [firstpage_image] =>[orig_patent_app_number] => 10494243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7353549 [patent_doc_number] => 20040249167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Substituted benzopyrans as selective estrogen receptor-beta agonists' [patent_app_type] => new [patent_app_number] => 10/493092 [patent_app_country] => US [patent_app_date] => 2004-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28355 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20040249167.pdf [firstpage_image] =>[orig_patent_app_number] => 10493092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1308606 [patent_doc_number] => 06617463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-09 [patent_title] => 'Method for the production of L-ascorbic acid by lactonization of 2-keto-L-gulonic acid or s2-keto-L-gulonate esters' [patent_app_type] => B2 [patent_app_number] => 10/275565 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7186 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617463.pdf [firstpage_image] =>[orig_patent_app_number] => 10275565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856786 [patent_doc_number] => 20030130287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/169399 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10368 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130287.pdf [firstpage_image] =>[orig_patent_app_number] => 10169399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1173811 [patent_doc_number] => 06750248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-15 [patent_title] => 'Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof' [patent_app_type] => B2 [patent_app_number] => 10/289079 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13793 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750248.pdf [firstpage_image] =>[orig_patent_app_number] => 10289079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248765 [patent_doc_number] => 06673929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-06 [patent_title] => 'Process for preparing growth hormone secretagogues' [patent_app_type] => B2 [patent_app_number] => 10/283720 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13274 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673929.pdf [firstpage_image] =>[orig_patent_app_number] => 10283720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835436 [patent_doc_number] => 20030162982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Method for the enantioselective preparation of 3,3-diphenyl-2,3-epoxy propionic acid esters' [patent_app_type] => new [patent_app_number] => 10/181457 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1967 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162982.pdf [firstpage_image] =>[orig_patent_app_number] => 10181457 [rel_patent_id] =>[rel_patent_doc_number] =>)